Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 poly

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:liuyao891233
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To observe the pharmacokinetics and pharmacodynamics of rabeprazole and compare serum gastrin concentrations in different CYP2C19 genotype groups.METHODS: The CYP2C19 genotype status of Chinese Han healthy volunteers was determined by polymerase chain reaction-restriction fragment length polymorphism method. Twenty H pylori-negative healthy subjects voluntary participated in the study. They were divided into the following three groups: homozygous extensive metabolizers (homEM), heterozygous extensive metabolizers (hetEM) and poor metabolizers (PM). After they orally received rabeprazole 20 mg once daily in the ming of d 1 and d 8, blood samples were collected at various time-points until 24 h after administration and intragastric pH values were monitored for 24 h by Digitrapper pH. Serum gastrin concentrations were measured by radioimmunoassay. Serum concentrations of rabeprazole were measured by high performance liquid chromatography.RESULTS: The mean AUC values for rabeprazole after a single and repeated doses were significantly different between the homEM and PM groups, but not between the homEM and hetEM, or the hetEM and PM groups. No significant differences in intragastric pH medians were observed among the three different genotype groups after a single dose or repeated doses. The ratio of pH medians between d 1 and d 8 ranged from 84% to 108%. The mean gastrin AUC values were also different among the three genotype groups, with a relative ratio of 1.0, 1.2 and 1.5 after a single dose and 1.0, 1.5 and 1.6 after repeated doses in the homEM, hetEM and PM groups, respectively. The gastrin AUC values among the three different genotype groups showed no significant difference either after a single dose or repeated doses.The subject who had lower intragastric acidity showed higher serum gastrin levels and concentrations of rabeprazole.CONCLUSION: In Chinese Han healthy people, the pharmacokinetics of rabeprazole are dependent on the CYP2C19 genotype status, but acid-inhibitory efficacy of rabeprazole and the gastrin level are not influenced significantly.
其他文献
时至今日,胰腺癌仍是预后最差的消化道恶性肿瘤之一,5年生存率约为6%[1].由于胰腺癌发病早期临床症状多不典型,患者就诊时多为晚期而丧失手术机会.根治性切除术(R0切除)是唯一可能治愈胰腺癌的方式,但只有15% ~ 20%患者可行手术治疗,根治术后5年生存率仅为15% ~27%[2-4]。
期刊
AIM: To detect microsatellite instability (MSI) in patients with hereditary nonpolyposis colorectal cancer or ordinary hereditary colorectal cancer and to provi
患者男,22岁,体质量70 kg,身高174 cm.因“体检发现左肾占位1个月余”于2013年入院.患者一般情况好,体温36.1℃,血压112/73 mmHg(1 mmHg =0.133 kPa),脉搏72次/min,ASA分级Ⅰ级.既往史:反复发生不明原因意识不清3个月余,每次发作均在清晨,喂饮糖水后缓解.检测血糖,1.7~2.2 mmol/L.各项常规检查(血、尿常规,生化,心电图,胸部X线片
期刊
目的探讨角膜内皮移植术治疗角膜失代偿的临床效果。方法白内障术后继发角膜失代偿6例(6眼)行角膜内皮移植术。用角膜板层刀分离供体角膜,取直径为13~14 mm深板层角膜内皮移植片植入受体眼前房。结果6例随访6个月以上。角膜均持续透明,内皮移植片贴附良好,术后6个月6例视力均有不同程度提高,由术前的数指~0.05,提高到0.12~0.3。角膜内皮细胞密度均明显增加,由术前≤656个/mm2增加到188
目的 探讨微创减重手术治疗2型糖尿病效果.方法 选择90例2016年2月-2018年2月2型糖尿病患者据术式分组.对照组开展传统方法治疗,观察组行微创减重手术治疗.比较两组2型糖尿病
中医药是中华民族的瑰宝.中医文化“走出去”的目的就是为了传播和弘扬中国优秀的文化思想.因此,其英文译本需要达到的功能就是给外国读者留下积极而深刻的印象,同时便于他们
期刊
目的观察EX-PRESS青光眼引流器植入术联合玻璃体内注射康柏西普治疗新生血管性青光眼的效果。方法2014年至2015年我院收治的新生血管性青光眼15例(15眼),先行康柏西普(Conbercept)玻璃体内注射,待虹膜新生血管消退后,行EX-PRESS青光眼引流器植入术。观察术后最佳矫正视力(BCVA)、眼压及并发症的发生。结果玻璃体内注射康柏西普3~5 d后虹膜及前房角新生血管消退,EX-PR
目的:探讨保乳手术与改良根治术治疗早期乳腺癌的临床效果.方法:在医院2014年11月至2015年12月期间诊治的早期乳腺癌患者中选取90例作研究对象,并按手术方式不同分组:改良组(
胰腺癌是恶性程度极高的消化道肿瘤,预后很差,其病因考虑与大量吸烟、糖尿病、慢性胰腺炎、肥胖、基因突变等有关[1].因胰腺癌起病隐匿,且早期症状不明显,使大多数患者失去手术治疗机会,即使将肿瘤切除,术后极易复发和转移.胰腺癌分子靶向治疗是近年来肿瘤治疗研究的热点.超声微泡造影剂是一种新的安全有效的载体,可从分子水平上介导肿瘤的靶向诊断和治疗。
期刊